Jarlath Bolger

My research focuses on ADAM22, a newly identified protein in endocrine-resistant breast cancer. I am investigating the functional role of ADAM22 and its potential as a drug target in treating breast cancer.

Breast Cancer Ireland

Lower Ground Floor
Breast Cancer Ireland
77 Merrion Square South
Dublin 2

Email: info@breastcancerireland.com
Tel: 00353-1-5160331

Charity No: Chy 19926

Breast Cancer Ireland has been incorporated as Breast Cancer Ireland CLG, trading as: Breast Cancer Ireland

X